1	1	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	Introduction	_	_	NN	_	_	_	_	_


1	Bacterial	_	_	JJ	_	_	_	_	_
2	Membrane	_	_	NNP	_	_	_	_	_
3	Vesicles	_	_	NNS	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	which	_	_	WDT	_	_	_	_	_
6	respond	_	_	VBP	_	_	_	_	_
7	to	_	_	TO	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	extracellular	_	_	JJ	_	_	_	_	_
10	vesicles	_	_	NNS	_	_	_	_	_
11	(	_	_	-LRB-	_	_	_	_	_


1	EVs	_	_	NN	_	_	_	_	_
2	)	_	_	-RRB-	_	_	_	_	_
3	definition	_	_	NN	_	_	_	_	_
4	criteria	_	_	NNS	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	membrane	_	_	NN	_	_	_	_	_
8	structures	_	_	NNS	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	produced	_	_	VBN	_	_	_	_	_
11	by	_	_	IN	_	_	_	_	_
12	Gram-negative	_	_	JJ	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	Gram-positive	_	_	JJ	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	Mycobacteria	_	_	JJ	_	_	_	_	_
17	microorganisms	_	_	NNS	_	_	_	_	_
18	during	_	_	IN	_	_	_	_	_
19	their	_	_	PRP$	_	_	_	_	_
20	growth	_	_	NN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	These	_	_	DT	_	_	_	_	_
2	elements	_	_	NNS	_	_	_	_	_
3	are	_	_	VBP	_	_	_	_	_
4	spherical	_	_	JJ	_	_	_	_	_
5	in	_	_	IN	_	_	_	_	_
6	shape	_	_	NN	_	_	_	_	_
7	,	_	_	,	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	an	_	_	DT	_	_	_	_	_
10	average	_	_	JJ	_	_	_	_	_
11	size	_	_	NN	_	_	_	_	_
12	in	_	_	IN	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	range	_	_	NN	_	_	_	_	_
15	from	_	_	IN	_	_	_	_	_
16	20	_	_	CD	_	_	_	_	_
17	to	_	_	TO	_	_	_	_	_
18	500	_	_	CD	_	_	_	_	_
19	nm	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	deliver	_	_	VB	_	_	_	_	_
22	several	_	_	JJ	_	_	_	_	_
23	components	_	_	NNS	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	such	_	_	JJ	_	_	_	_	_
26	as	_	_	IN	_	_	_	_	_
27	proteins	_	_	NNS	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	nucleic	_	_	JJ	_	_	_	_	_
30	acids	_	_	NNS	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	phospholipids	_	_	NNS	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	has	_	_	VBZ	_	_	_	_	_
3	been	_	_	VBN	_	_	_	_	_
4	reported	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	EVs	_	_	NNP	_	_	_	_	_
7	are	_	_	VBP	_	_	_	_	_
8	involved	_	_	VBN	_	_	_	_	_
9	in	_	_	IN	_	_	_	_	_
10	a	_	_	DT	_	_	_	_	_
11	number	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	physiological	_	_	JJ	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	pathological	_	_	JJ	_	_	_	_	_
16	mechanisms	_	_	NNS	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	including	_	_	VBG	_	_	_	_	_
19	biofilm	_	_	NN	_	_	_	_	_
20	formation	_	_	NN	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	inter-cellular	_	_	JJ	_	_	_	_	_
23	cross-talk	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	as	_	_	RB	_	_	_	_	_
26	well	_	_	RB	_	_	_	_	_
27	as	_	_	IN	_	_	_	_	_
28	bacteria	_	_	NN	_	_	_	_	_
29	–	_	_	:	_	_	_	_	_
30	host	_	_	NN	_	_	_	_	_
31	and	_	_	CC	_	_	_	_	_
32	bacterium	_	_	NN	_	_	_	_	_
33	–	_	_	:	_	_	_	_	_
34	phage	_	_	NN	_	_	_	_	_
35	interactions	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	Many	_	_	JJ	_	_	_	_	_
2	studies	_	_	NNS	_	_	_	_	_
3	support	_	_	VBP	_	_	_	_	_
4	the	_	_	DT	_	_	_	_	_
5	hypothesis	_	_	NN	_	_	_	_	_
6	that	_	_	IN	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	generation	_	_	NN	_	_	_	_	_
9	of	_	_	IN	_	_	_	_	_
10	EVs	_	_	NNP	_	_	_	_	_
11	is	_	_	VBZ	_	_	_	_	_
12	a	_	_	DT	_	_	_	_	_
13	controlled	_	_	VBN	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	regulated	_	_	VBN	_	_	_	_	_
16	process	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	although	_	_	IN	_	_	_	_	_
19	Turnbull	_	_	NNP	_	_	_	_	_
20	et	_	_	FW	_	_	_	_	_
21	al.	_	_	FW	_	_	_	_	_
22	demonstrated	_	_	VBD	_	_	_	_	_
23	that	_	_	IN	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	EVs	_	_	NNP	_	_	_	_	_
26	’	_	_	POS	_	_	_	_	_
27	biogenesis	_	_	NN	_	_	_	_	_
28	is	_	_	VBZ	_	_	_	_	_
29	associated	_	_	VBN	_	_	_	_	_
30	with	_	_	IN	_	_	_	_	_
31	a	_	_	DT	_	_	_	_	_
32	rearrangement	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	the	_	_	DT	_	_	_	_	_
35	bacterial	_	_	JJ	_	_	_	_	_
36	membranes	_	_	NNS	_	_	_	_	_
37	,	_	_	,	_	_	_	_	_
38	derived	_	_	VBN	_	_	_	_	_
39	from	_	_	IN	_	_	_	_	_
40	lysed	_	_	VBN	_	_	_	_	_
41	cells	_	_	NNS	_	_	_	_	_
42	,	_	_	,	_	_	_	_	_
43	which	_	_	WDT	_	_	_	_	_
44	incorporate	_	_	VBP	_	_	_	_	_
45	soluble	_	_	JJ	_	_	_	_	_
46	molecules	_	_	NNS	_	_	_	_	_
47	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	is	_	_	VBZ	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	known	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	EVs	_	_	NNP	_	_	_	_	_
7	fuse	_	_	VBP	_	_	_	_	_
8	with	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	outer	_	_	JJ	_	_	_	_	_
11	membrane	_	_	NN	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	Gram-negative	_	_	JJ	_	_	_	_	_
14	cells	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	while	_	_	IN	_	_	_	_	_
17	they	_	_	PRP	_	_	_	_	_
18	are	_	_	VBP	_	_	_	_	_
19	not	_	_	RB	_	_	_	_	_
20	able	_	_	JJ	_	_	_	_	_
21	to	_	_	TO	_	_	_	_	_
22	interact	_	_	VB	_	_	_	_	_
23	with	_	_	IN	_	_	_	_	_
24	Gram-positive	_	_	JJ	_	_	_	_	_
25	bacteria	_	_	NNS	_	_	_	_	_
26	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	was	_	_	VBD	_	_	_	_	_
3	demonstrated	_	_	VBN	_	_	_	_	_
4	that	_	_	IN	_	_	_	_	_
5	EVs	_	_	NNP	_	_	_	_	_
6	stemming	_	_	VBG	_	_	_	_	_
7	from	_	_	IN	_	_	_	_	_
8	Pseudomonas	_	_	NNP	_	_	_	_	_
9	aeruginosa	_	_	NN	_	_	_	_	_
10	are	_	_	VBP	_	_	_	_	_
11	able	_	_	JJ	_	_	_	_	_
12	to	_	_	TO	_	_	_	_	_
13	interact	_	_	VB	_	_	_	_	_
14	with	_	_	IN	_	_	_	_	_
15	Shigella	_	_	NNP	_	_	_	_	_
16	flexneri	_	_	NNP	_	_	_	_	_
17	pouring	_	_	VBG	_	_	_	_	_
18	their	_	_	PRP$	_	_	_	_	_
19	content	_	_	NN	_	_	_	_	_
20	into	_	_	IN	_	_	_	_	_
21	the	_	_	DT	_	_	_	_	_
22	periplasm	_	_	NN	_	_	_	_	_
23	of	_	_	IN	_	_	_	_	_
24	eukaryotic	_	_	JJ	_	_	_	_	_
25	cells	_	_	NNS	_	_	_	_	_
26	;	_	_	:	_	_	_	_	_
27	conversely	_	_	RB	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	EVs	_	_	NNP	_	_	_	_	_
30	derived	_	_	VBN	_	_	_	_	_
31	from	_	_	IN	_	_	_	_	_
32	P.	_	_	FW	_	_	_	_	_
33	aeruginosa	_	_	FW	_	_	_	_	_
34	adhere	_	_	VBP	_	_	_	_	_
35	to	_	_	TO	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	cell	_	_	NN	_	_	_	_	_
38	wall	_	_	NN	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	Staphylococcus	_	_	NNP	_	_	_	_	_
41	aureus	_	_	NN	_	_	_	_	_
42	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	EVs	_	_	NNP	_	_	_	_	_
3	composition	_	_	NN	_	_	_	_	_
4	and	_	_	CC	_	_	_	_	_
5	content	_	_	NN	_	_	_	_	_
6	are	_	_	VBP	_	_	_	_	_
7	strictly	_	_	RB	_	_	_	_	_
8	dependent	_	_	VBN	_	_	_	_	_
9	on	_	_	IN	_	_	_	_	_
10	the	_	_	DT	_	_	_	_	_
11	environmental	_	_	JJ	_	_	_	_	_
12	conditions	_	_	NNS	_	_	_	_	_
13	where	_	_	WRB	_	_	_	_	_
14	they	_	_	PRP	_	_	_	_	_
15	are	_	_	VBP	_	_	_	_	_
16	generated	_	_	VBN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	as	_	_	RB	_	_	_	_	_
19	well	_	_	RB	_	_	_	_	_
20	as	_	_	IN	_	_	_	_	_
21	on	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	bacterial	_	_	JJ	_	_	_	_	_
24	species	_	_	NNS	_	_	_	_	_
25	from	_	_	IN	_	_	_	_	_
26	which	_	_	WDT	_	_	_	_	_
27	they	_	_	PRP	_	_	_	_	_
28	are	_	_	VBP	_	_	_	_	_
29	produced	_	_	VBN	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	on	_	_	IN	_	_	_	_	_
32	their	_	_	PRP$	_	_	_	_	_
33	growth	_	_	NN	_	_	_	_	_
34	phase	_	_	NN	_	_	_	_	_
35	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	example	_	_	NN	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	iron-limiting	_	_	JJ	_	_	_	_	_
5	conditions	_	_	NNS	_	_	_	_	_
6	increase	_	_	VBP	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	EVs	_	_	NN	_	_	_	_	_
9	production	_	_	NN	_	_	_	_	_
10	from	_	_	IN	_	_	_	_	_
11	Helicobacter	_	_	NN	_	_	_	_	_
12	pylori	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	Haemophilus	_	_	NN	_	_	_	_	_
15	influenzae	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	Escherichia	_	_	NNP	_	_	_	_	_
18	coli	_	_	NNP	_	_	_	_	_
19	,	_	_	,	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	Vibrio	_	_	NN	_	_	_	_	_
22	cholera	_	_	NN	_	_	_	_	_
23	;	_	_	:	_	_	_	_	_
24	the	_	_	DT	_	_	_	_	_
25	oxygen	_	_	NN	_	_	_	_	_
26	availability	_	_	NN	_	_	_	_	_
27	affects	_	_	VBZ	_	_	_	_	_
28	the	_	_	DT	_	_	_	_	_
29	generation	_	_	NN	_	_	_	_	_
30	of	_	_	IN	_	_	_	_	_
31	EVs	_	_	NN	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	the	_	_	DT	_	_	_	_	_
34	antibiotic	_	_	JJ	_	_	_	_	_
35	treatment	_	_	NN	_	_	_	_	_
36	(	_	_	-LRB-	_	_	_	_	_
37	i.	_	_	FW	_	_	_	_	_
38	e.	_	_	FW	_	_	_	_	_
39	,	_	_	,	_	_	_	_	_
40	polymyxin	_	_	NN	_	_	_	_	_
41	B	_	_	NN	_	_	_	_	_
42	or	_	_	CC	_	_	_	_	_
43	colistin	_	_	NN	_	_	_	_	_
44	)	_	_	-RRB-	_	_	_	_	_
45	promotes	_	_	VBZ	_	_	_	_	_
46	an	_	_	DT	_	_	_	_	_
47	increase	_	_	NN	_	_	_	_	_
48	of	_	_	IN	_	_	_	_	_
49	EVs	_	_	NN	_	_	_	_	_
50	production	_	_	NN	_	_	_	_	_
51	that	_	_	WDT	_	_	_	_	_
52	confers	_	_	VBZ	_	_	_	_	_
53	protection	_	_	NN	_	_	_	_	_
54	to	_	_	TO	_	_	_	_	_
55	the	_	_	DT	_	_	_	_	_
56	bacterial	_	_	JJ	_	_	_	_	_
57	cells	_	_	NNS	_	_	_	_	_
58	,	_	_	,	_	_	_	_	_
59	thus	_	_	RB	_	_	_	_	_
60	allowing	_	_	VBG	_	_	_	_	_
61	their	_	_	PRP$	_	_	_	_	_
62	survival	_	_	NN	_	_	_	_	_
63	.	_	_	.	_	_	_	_	_


1	A	_	_	DT	_	_	_	_	_
2	previous	_	_	JJ	_	_	_	_	_
3	study	_	_	NN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	performed	_	_	VBN	_	_	_	_	_
6	on	_	_	IN	_	_	_	_	_
7	Stenotrophomonas	_	_	NNP	_	_	_	_	_
8	maltophilia	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	demonstrated	_	_	VBD	_	_	_	_	_
11	that	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	imipenem	_	_	NN	_	_	_	_	_
14	treatment	_	_	NN	_	_	_	_	_
15	increases	_	_	VBZ	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	production	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	EVs	_	_	NN	_	_	_	_	_
20	delivering	_	_	VBG	_	_	_	_	_
21	β-lactamases	_	_	NNS	_	_	_	_	_
22	.	_	_	.	_	_	_	_	_


1	Modifications	_	_	NNS	_	_	_	_	_
2	in	_	_	IN	_	_	_	_	_
3	terms	_	_	NNS	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	EVs	_	_	NN	_	_	_	_	_
6	production	_	_	NN	_	_	_	_	_
7	and	_	_	CC	_	_	_	_	_
8	content	_	_	NN	_	_	_	_	_
9	might	_	_	MD	_	_	_	_	_
10	also	_	_	RB	_	_	_	_	_
11	be	_	_	VB	_	_	_	_	_
12	associated	_	_	VBN	_	_	_	_	_
13	with	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	growth	_	_	NN	_	_	_	_	_
16	phase	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	as	_	_	RB	_	_	_	_	_
19	well	_	_	RB	_	_	_	_	_
20	as	_	_	IN	_	_	_	_	_
21	with	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	bacterial	_	_	JJ	_	_	_	_	_
24	phenotype	_	_	NN	_	_	_	_	_
25	(	_	_	-LRB-	_	_	_	_	_
26	biofilm	_	_	NN	_	_	_	_	_
27	or	_	_	CC	_	_	_	_	_
28	planktonic	_	_	NN	_	_	_	_	_
29	)	_	_	-RRB-	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	the	_	_	DT	_	_	_	_	_
32	media	_	_	NN	_	_	_	_	_
33	composition	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_
35	Park	_	_	NNP	_	_	_	_	_
36	et	_	_	FW	_	_	_	_	_
37	al.	_	_	FW	_	_	_	_	_
38	demonstrated	_	_	VBD	_	_	_	_	_
39	that	_	_	IN	_	_	_	_	_
40	EVs	_	_	NN	_	_	_	_	_
41	associated	_	_	VBN	_	_	_	_	_
42	to	_	_	TO	_	_	_	_	_
43	the	_	_	DT	_	_	_	_	_
44	P.	_	_	NN	_	_	_	_	_
45	aeruginosa	_	_	NN	_	_	_	_	_
46	biofilm	_	_	NN	_	_	_	_	_
47	phenotype	_	_	NN	_	_	_	_	_
48	showed	_	_	VBD	_	_	_	_	_
49	a	_	_	DT	_	_	_	_	_
50	unique	_	_	JJ	_	_	_	_	_
51	proteome	_	_	NN	_	_	_	_	_
52	profile	_	_	NN	_	_	_	_	_
53	,	_	_	,	_	_	_	_	_
54	with	_	_	IN	_	_	_	_	_
55	respect	_	_	NN	_	_	_	_	_
56	to	_	_	TO	_	_	_	_	_
57	the	_	_	DT	_	_	_	_	_
58	one	_	_	CD	_	_	_	_	_
59	carried	_	_	VBN	_	_	_	_	_
60	by	_	_	IN	_	_	_	_	_
61	EVs	_	_	NNP	_	_	_	_	_
62	stemming	_	_	VBG	_	_	_	_	_
63	from	_	_	IN	_	_	_	_	_
64	its	_	_	PRP$	_	_	_	_	_
65	planktonic	_	_	JJ	_	_	_	_	_
66	counterpart	_	_	NN	_	_	_	_	_
67	.	_	_	.	_	_	_	_	_


1	Helicobacter	_	_	NN	_	_	_	_	_
2	pylori	_	_	NN	_	_	_	_	_
3	ATCC	_	_	NNP	_	_	_	_	_
4	43629	_	_	CD	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	Lactobacillus	_	_	NNP	_	_	_	_	_
7	reuteri	_	_	NN	_	_	_	_	_
8	DSM	_	_	NN	_	_	_	_	_
9	17938	_	_	CD	_	_	_	_	_
10	are	_	_	VBP	_	_	_	_	_
11	biofilm-producing	_	_	JJ	_	_	_	_	_
12	strains	_	_	NNS	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	and	_	_	CC	_	_	_	_	_
15	both	_	_	DT	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	planktonic	_	_	JJ	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	biofilm	_	_	NN	_	_	_	_	_
21	phenotypes	_	_	NNS	_	_	_	_	_
22	generate	_	_	VBP	_	_	_	_	_
23	EVs	_	_	NN	_	_	_	_	_
24	(	_	_	-LRB-	_	_	_	_	_
25	pEVs	_	_	NNS	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	bEVs	_	_	NNS	_	_	_	_	_
28	,	_	_	,	_	_	_	_	_
29	respectively	_	_	RB	_	_	_	_	_
30	)	_	_	-RRB-	_	_	_	_	_
31	carrying	_	_	VBG	_	_	_	_	_
32	extracellular	_	_	JJ	_	_	_	_	_
33	DNA	_	_	NN	_	_	_	_	_
34	(	_	_	-LRB-	_	_	_	_	_
35	eDNA).	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	particular	_	_	JJ	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	H.	_	_	NNP	_	_	_	_	_
5	pylori	_	_	NNP	_	_	_	_	_
6	-derived	_	_	VBN	_	_	_	_	_
7	bEVs	_	_	NNS	_	_	_	_	_
8	seemed	_	_	VBD	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	“	_	_	``	_	_	_	_	_
11	bridge	_	_	NN	_	_	_	_	_
12	”	_	_	''	_	_	_	_	_
13	bacterial	_	_	JJ	_	_	_	_	_
14	cells	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	thus	_	_	RB	_	_	_	_	_
17	playing	_	_	VBG	_	_	_	_	_
18	a	_	_	DT	_	_	_	_	_
19	possible	_	_	JJ	_	_	_	_	_
20	structural	_	_	JJ	_	_	_	_	_
21	role	_	_	NN	_	_	_	_	_
22	;	_	_	:	_	_	_	_	_
23	however	_	_	RB	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	the	_	_	DT	_	_	_	_	_
26	fact	_	_	NN	_	_	_	_	_
27	that	_	_	IN	_	_	_	_	_
28	eDNA	_	_	NNP	_	_	_	_	_
29	are	_	_	VBP	_	_	_	_	_
30	carried	_	_	VBN	_	_	_	_	_
31	by	_	_	IN	_	_	_	_	_
32	EVs	_	_	NNP	_	_	_	_	_
33	,	_	_	,	_	_	_	_	_
34	may	_	_	MD	_	_	_	_	_
35	protect	_	_	VB	_	_	_	_	_
36	the	_	_	DT	_	_	_	_	_
37	eDNA	_	_	NN	_	_	_	_	_
38	from	_	_	IN	_	_	_	_	_
39	the	_	_	DT	_	_	_	_	_
40	enzymatic	_	_	JJ	_	_	_	_	_
41	activity	_	_	NN	_	_	_	_	_
42	of	_	_	IN	_	_	_	_	_
43	DNase	_	_	NNP	_	_	_	_	_
44	I	_	_	PRP	_	_	_	_	_
45	in	_	_	IN	_	_	_	_	_
46	breaking	_	_	VBG	_	_	_	_	_
47	up	_	_	RP	_	_	_	_	_
48	the	_	_	DT	_	_	_	_	_
49	biofilm	_	_	NN	_	_	_	_	_
50	.	_	_	.	_	_	_	_	_


1	It	_	_	PRP	_	_	_	_	_
2	cannot	_	_	MD	_	_	_	_	_
3	be	_	_	VB	_	_	_	_	_
4	dismissed	_	_	VBN	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	EVs	_	_	NNP	_	_	_	_	_
7	produced	_	_	VBN	_	_	_	_	_
8	from	_	_	IN	_	_	_	_	_
9	the	_	_	DT	_	_	_	_	_
10	biofilm	_	_	NN	_	_	_	_	_
11	phenotype	_	_	NN	_	_	_	_	_
12	may	_	_	MD	_	_	_	_	_
13	represent	_	_	VB	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	shuttle	_	_	NN	_	_	_	_	_
16	for	_	_	IN	_	_	_	_	_
17	eDNA	_	_	NNP	_	_	_	_	_
18	transport	_	_	NN	_	_	_	_	_
19	.	_	_	.	_	_	_	_	_


1	For	_	_	IN	_	_	_	_	_
2	all	_	_	DT	_	_	_	_	_
3	of	_	_	IN	_	_	_	_	_
4	these	_	_	DT	_	_	_	_	_
5	reasons	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	we	_	_	PRP	_	_	_	_	_
8	aimed	_	_	VBD	_	_	_	_	_
9	to	_	_	TO	_	_	_	_	_
10	optimize	_	_	VB	_	_	_	_	_
11	a	_	_	DT	_	_	_	_	_
12	simplified	_	_	VBN	_	_	_	_	_
13	Polychromatic	_	_	JJ	_	_	_	_	_
14	Flow	_	_	NN	_	_	_	_	_
15	Cytometry	_	_	NN	_	_	_	_	_
16	(	_	_	-LRB-	_	_	_	_	_
17	PFC	_	_	NN	_	_	_	_	_
18	)	_	_	-RRB-	_	_	_	_	_
19	method	_	_	NN	_	_	_	_	_
20	for	_	_	IN	_	_	_	_	_
21	a	_	_	DT	_	_	_	_	_
22	fast	_	_	JJ	_	_	_	_	_
23	identification	_	_	NN	_	_	_	_	_
24	,	_	_	,	_	_	_	_	_
25	enumeration	_	_	NN	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	characterization	_	_	NN	_	_	_	_	_
28	of	_	_	IN	_	_	_	_	_
29	bacterial	_	_	JJ	_	_	_	_	_
30	derived	_	_	VBN	_	_	_	_	_
31	EVs	_	_	NN	_	_	_	_	_
32	,	_	_	,	_	_	_	_	_
33	as	_	_	RB	_	_	_	_	_
34	well	_	_	RB	_	_	_	_	_
35	as	_	_	IN	_	_	_	_	_
36	for	_	_	IN	_	_	_	_	_
37	the	_	_	DT	_	_	_	_	_
38	analysis	_	_	NN	_	_	_	_	_
39	of	_	_	IN	_	_	_	_	_
40	their	_	_	PRP$	_	_	_	_	_
41	eDNA-associated	_	_	JJ	_	_	_	_	_
42	subtypes	_	_	NNS	_	_	_	_	_
43	,	_	_	,	_	_	_	_	_
44	produced	_	_	VBN	_	_	_	_	_
45	by	_	_	IN	_	_	_	_	_
46	the	_	_	DT	_	_	_	_	_
47	planktonic	_	_	JJ	_	_	_	_	_
48	and	_	_	CC	_	_	_	_	_
49	the	_	_	DT	_	_	_	_	_
50	biofilm	_	_	NN	_	_	_	_	_
51	phenotypes	_	_	NNS	_	_	_	_	_
52	of	_	_	IN	_	_	_	_	_
53	a	_	_	DT	_	_	_	_	_
54	Gram-negative	_	_	JJ	_	_	_	_	_
55	(	_	_	-LRB-	_	_	_	_	_
56	H.	_	_	NNP	_	_	_	_	_
57	pylori	_	_	NNP	_	_	_	_	_
58	ATCC	_	_	NNP	_	_	_	_	_
59	43629	_	_	CD	_	_	_	_	_
60	)	_	_	-RRB-	_	_	_	_	_
61	and	_	_	CC	_	_	_	_	_
62	a	_	_	DT	_	_	_	_	_
63	Gram-positive	_	_	JJ	_	_	_	_	_
64	(	_	_	-LRB-	_	_	_	_	_
65	L.	_	_	NNP	_	_	_	_	_
66	reuteri	_	_	NNP	_	_	_	_	_
67	DSM	_	_	NNP	_	_	_	_	_
68	17938	_	_	CD	_	_	_	_	_
69	)	_	_	-RRB-	_	_	_	_	_
70	bacterium	_	_	NN	_	_	_	_	_
71	.	_	_	.	_	_	_	_	_


1	We	_	_	PRP	_	_	_	_	_
2	demonstrated	_	_	VBD	_	_	_	_	_
3	that	_	_	IN	_	_	_	_	_
4	PFC	_	_	NNP	_	_	_	_	_
5	can	_	_	MD	_	_	_	_	_
6	be	_	_	VB	_	_	_	_	_
7	used	_	_	VBN	_	_	_	_	_
8	as	_	_	IN	_	_	_	_	_
9	a	_	_	DT	_	_	_	_	_
10	tool	_	_	NN	_	_	_	_	_
11	to	_	_	TO	_	_	_	_	_
12	study	_	_	VB	_	_	_	_	_
13	the	_	_	DT	_	_	_	_	_
14	modifications	_	_	NNS	_	_	_	_	_
15	of	_	_	IN	_	_	_	_	_
16	EVs	_	_	NN	_	_	_	_	_
17	production	_	_	NN	_	_	_	_	_
18	under	_	_	IN	_	_	_	_	_
19	different	_	_	JJ	_	_	_	_	_
20	environmental	_	_	JJ	_	_	_	_	_
21	conditions	_	_	NNS	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	as	_	_	RB	_	_	_	_	_
24	well	_	_	RB	_	_	_	_	_
25	as	_	_	IN	_	_	_	_	_
26	for	_	_	IN	_	_	_	_	_
27	the	_	_	DT	_	_	_	_	_
28	detection	_	_	NN	_	_	_	_	_
29	and	_	_	CC	_	_	_	_	_
30	enumeration	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	bacterial	_	_	JJ	_	_	_	_	_
33	derived	_	_	VBN	_	_	_	_	_
34	EVs	_	_	NN	_	_	_	_	_
35	,	_	_	,	_	_	_	_	_
36	and	_	_	CC	_	_	_	_	_
37	in	_	_	IN	_	_	_	_	_
38	particular	_	_	JJ	_	_	_	_	_
39	eDNA-associated	_	_	JJ	_	_	_	_	_
40	EVs	_	_	NN	_	_	_	_	_
41	,	_	_	,	_	_	_	_	_
42	in	_	_	IN	_	_	_	_	_
43	clinical	_	_	JJ	_	_	_	_	_
44	samples	_	_	NNS	_	_	_	_	_
45	.	_	_	.	_	_	_	_	_

